• linkedin
  • Increase Font
  • Sharebar

    Every New FDA Drug Approval in 2017

    The last 12 drugs approved in the year, along with the other 34.

     

    Vyzulta image

    VYZULTA (latanoprostene bunod ophthalmic solution), Bausch + Lomb

    Indications: A prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    Dosage: One drop in the affected eye(s) once daily in the evening.

    Contraindications: None

    Click here to read the full label

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available